Diagnostics, Biomarkers & Liquid Biopsy This slice is part of the broader Healthcare & Biotech theme.
Diagnostics, Biomarkers & Liquid Biopsy names often move on drivers that differ from the rest of Healthcare & Biotech. Isolating this segment keeps earnings logic and news flow aligned with one part of the value chain.
Membership is based on Next Big Trend classification under Healthcare & Biotech → Diagnostics, Biomarkers & Liquid Biopsy. Save the list as a watchlist to track updates without rebuilding Screener filters.
| Company | |||||||
|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $180.3B | +1.86% | -6.41% | -20.50% | -24.78% | 56 |
| IDXX | IDEXX Laboratories, Inc. | $41.2B | -0.89% | -0.39% | -24.15% | -18.20% | 72 |
| DGX | Quest Diagnostics Incorporated | $26.2B | -0.12% | -1.97% | +34.74% | +28.55% | 68 |
| CRL | Charles River Laboratories International, Inc. | $14.0B | +3.89% | +7.06% | +49.39% | +75.19% | 87 |
| RDY | Dr. Reddy's Laboratories Ltd | $10.4B | -0.41% | +2.69% | -12.49% | -12.43% | 81 |
| BIO | Bio-Rad Laboratories, Inc. | $10.4B | +1.36% | -4.40% | +18.95% | +21.54% | 62 |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.8B | 0.00% | 0.00% | +17.50% | +28.15% | 74 |
| CHRN | ChronoScale Holdings Corporation | $2.9B | -1.76% | +4.68% | +120.25% | +78.88% | 67 |
| FRNM | Freenome, Inc. | $1.7B | +1.09% | +0.38% | +21.34% | +49.15% | 75 |
| XGN | Exagen Inc. | $198M | +3.55% | +11.76% | +34.38% | -25.05% | 90 |
| LUCD | Lucid Diagnostics Inc. | $121M | +2.41% | -20.83% | -40.36% | -38.09% | 28 |
| IMDX | Insight Molecular Diagnostics Inc. | $117M | -5.48% | -20.00% | -56.27% | 0.00% | 29 |
| QUCY | Quantum Cyber N.V. | $108M | +2.96% | 0.00% | -86.64% | -90.93% | 73 |
| MDXH | MDxHealth SA | $55M | +0.75% | -16.11% | -67.81% | -75.70% | 36 |
| MBAI | MBody AI Ltd. | $48M | -4.75% | -53.12% | -85.83% | -89.80% | 2 |
| PRPO | Precipio, Inc. | $43M | +2.02% | -9.41% | +0.91% | +14.75% | 50 |
| NDRA | ENDRA Life Sciences Inc. | $9M | +0.85% | +1.72% | +30.91% | -4.51% | 79 |
| XWEL | XWELL, Inc. | $8M | +11.88% | -1.19% | -37.27% | -70.85% | 70 |
| CODX | Co-Diagnostics, Inc. | $8M | +0.93% | -2.68% | -94.07% | -98.35% | 67 |
| CDIO | Cardio Diagnostics Holdings Inc. | $6M | -3.12% | -10.14% | -61.65% | -76.36% | 49 |
| ISPC | iSpecimen Inc. | $3M | -4.39% | -31.45% | -89.52% | -97.55% | 12 |
| BJDX | Bluejay Diagnostics, Inc. | $1M | -3.60% | -19.25% | -68.90% | -90.31% | 30 |
Companies classified under the Healthcare & Biotech theme and the Diagnostics, Biomarkers & Liquid Biopsy sub-theme within Next Big Trend's catalog.
Yes. Signed-in users can save the current constituents from this page as a named watchlist.
No. It is a research universe for screening, not a recommendation.